Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'22
Mar'21
Net Sales
337.42
242.75
Other Operating Income
0.00
0.00
Total Operating income
337.42
242.75
Raw Material Cost
87.38
57.27
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
53.78
41.66
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
122.42
94.83
Total Expenditure (Excl Depreciation)
263.58
193.76
Operating Profit (PBDIT) excl Other Income
73.84
48.99
Other Income
4.99
6.11
Operating Profit (PBDIT)
78.83
55.10
Interest
11.15
13.75
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
67.68
41.35
Depreciation
13.59
12.47
Profit Before Tax
54.08
28.88
Tax
12.42
7.79
Provisions and contingencies
0.00
0.00
Profit After Tax
41.66
21.09
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
41.66
21.09
Share in Profit of Associates
0.04
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
41.70
21.09
Equity Capital
79.90
17.94
Face Value
10.0
10.0
Reserves
78.28
75.93
Earnings per share (EPS)
5.22
3.92
Diluted Earnings per share
5.21
11.76
Operating Profit Margin (Excl OI)
21.88%
20.18%
Gross Profit Margin
20.06%
17.03%
PAT Margin
12.35%
8.69%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 1.72% vs 10.84% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 4.50% vs 22.46% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -5.10% vs 18.13% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -51.20% vs -22.38% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of GPT Healthcare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
337.42
0
337.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
337.42
0
337.42
Raw Material Cost
87.38
0
87.38
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.00
0
0.00
Employee Cost
53.78
0
53.78
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
122.42
0.00
122.42
Total Expenditure (Excl Depreciation)
263.58
0
263.58
Operating Profit (PBDIT) excl Other Income
73.84
0.00
73.84
Other Income
4.99
0
4.99
Operating Profit (PBDIT)
78.83
0
78.83
Interest
11.15
0
11.15
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
67.68
0
67.68
Depreciation
13.59
0
13.59
Profit Before Tax
54.08
0
54.08
Tax
12.42
0
12.42
Provisions and contingencies
0.00
0
0.00
Profit After Tax
41.66
0
41.66
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
41.66
0
41.66
Share in Profit of Associates
0.04
0
0.04
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.70
0
41.70
Equity Capital
79.90
0
79.90
Face Value
10.00
0
0.00
Reserves
78.28
0
78.28
Earnings per share (EPS)
5.22
0
5.22
Diluted Earnings per share
5.21
0
5.21
Operating Profit Margin (Excl OI)
21.88%
0%
0.00
21.88%
Gross Profit Margin
20.06%
0%
0.00
20.06%
PAT Margin
12.35%
0%
0.00
12.35%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 407.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1.72% vs 10.84% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 49.92 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.50% vs 22.46% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 83.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.10% vs 18.13% in Mar 2024
Annual - Interest
Interest 3.47 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -51.20% vs -22.38% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.47%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
